Peripheral initiators of muscle pain are virtually unknown, but likely key to development of chronic pain after muscle insult. The current study tested the hypothesis that ASIC3 in muscle is necessary for development of cutaneous mechanical, but not heat, hyperalgesia induced by muscle inflammation. Using mechanical and heat stimuli, we assessed behavioral responses in ASIC3À/À and ASIC3+/+ mice after induction of carrageenan muscle inflammation. ASIC3À/À mice did not develop cutaneous mechanical hyperalgesia after muscle inflammation when compared to ASIC3+/+ mice; heat hyperalgesia developed similarly between groups. We then tested if the phenotype could be rescued in ASIC3À/À mice by using a recombinant herpes virus vector to express ASIC3 in skin (where testing occurred) or muscle (where inflammation occurred). Infection of mouse DRG neurons with ASIC3-encoding virus resulted in functional expression of ASICs. Injection of ASIC3-encoding virus into muscle or skin of ASIC3À/À mice resulted in ASIC3 mRNA in DRG and protein expression in DRG and the peripheral injection site. Injection of ASIC3-encoding virus into muscle, but not skin, resulted in development of mechanical hyperalgesia similar to that observed in ASIC3+/+ mice. Thus, ASIC3 in primary afferent fibers innervating muscle is critical to development of hyperalgesia that results from muscle insult. Ó
Introduction
Chronic musculoskeletal pain is disabling and difficult to treat, and includes both inflammatory and non-inflammatory components. Chronic musculoskeletal pain conditions such as repetitive strain injury and tendonitis are clearly associated with peripheral tissue damage that includes inflammation of the muscle (Barr and Barbe, 2002; Barr et al., 2004; Stauber, 2004) . Data from the Bureau of Labor and Statistics state that 53% of the private workforce had musculoskeletal pain over the last 2 weeks, and 13% of these lost productive work time with losses estimated at $61 billion per year. 
